“…α‐Synuclein‐containing aggregates known as Lewy Bodies are a hallmark of PD, and, so far, 6 mutations in α‐synuclein have been associated with familial PD (Dehay & Fernagut, 2016). α‐Synuclein was first identified as a SUMO substrate by Dorval and Fraser (Dorval & Fraser, 2006), and subsequent work demonstrated that 11 of the 15 lysines in α‐synuclein can be SUMOylated (Kim et al., 2011; Krumova et al, 2011; Oh, Kim, Mouradian, & Chung, 2011; Rousseaux, de Haro, & Lasagna‐Reeves, 2016; Rousseaux et al, 2018). SUMOylation has been variously proposed to regulate α‐synuclein localization, turnover, aggregation and toxicity (Kim et al., 2011; Krumova et al., 2011; Oh et al., 2011; Rousseaux et al, 2016, 2018), suggesting that many aspects of α‐synuclein behaviour are under the control of SUMOylation, potentially depending on the specific lysines modified, the cellular context, and experimental system used.…”